These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12053422)

  • 41. CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN HEALTHCARE SYSTEM IN SLOVENIA.
    Prevolnik Rupel V
    Int J Technol Assess Health Care; 2017 Jan; 33(3):360-364. PubMed ID: 28434423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The International Network of Agencies for Health Technology Assessment (INAHTA) or the need for collaboration in evaluating health technologies].
    Asua Batarrita J
    Med Clin (Barc); 1999; 112 Suppl 1():86-9. PubMed ID: 10618805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the Canadian Coordinating Office for Health Technology Assessment.
    Battista RN; Feeny DH; Hodge MJ
    Int J Technol Assess Health Care; 1995; 11(1):102-16. PubMed ID: 7706007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of health technology assessment in Central Europe.
    Kárpáti K; Sándor J
    Int J Technol Assess Health Care; 2009 Oct; 25(4):596-7. PubMed ID: 19845992
    [No Abstract]   [Full Text] [Related]  

  • 45. ANALYSIS OF DUPLICATION AND TIMING OF HEALTH TECHNOLOGY ASSESSMENTS ON MEDICAL DEVICES IN EUROPE.
    Hawlik K; Rummel P; Wild C
    Int J Technol Assess Health Care; 2018 Jan; 34(1):18-26. PubMed ID: 29258630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Research on digestive and liver diseases: a priority for Europe - the societal importance of gastrointestinal diseases and research.
    Stockbrugger R; Quaglio G; O'Morain C; Rubig P; Manns M
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):879-84. PubMed ID: 23628975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. OVERVIEW ON THE CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN THE HEALTHCARE SYSTEM IN HUNGARY.
    Németh B; Csanádi M; Kaló Z
    Int J Technol Assess Health Care; 2017 Jan; 33(3):333-338. PubMed ID: 28434433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health Technology Assessment International 7th Annual Meeting: Dublin, Ireland, 6–9 June 2010.
    Fogarty E; Tilson L; Ryan M; Barry M
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):501-3. PubMed ID: 20950064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cooperation within Europe.
    Carter HE
    Vet Rec; 1990 Oct; 127(17):433-4. PubMed ID: 2264249
    [No Abstract]   [Full Text] [Related]  

  • 50. [Marketing authorization for pharmaceuticals: the necessity of European collaboration].
    Seitz R; Enzmann H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):703-4. PubMed ID: 18592336
    [No Abstract]   [Full Text] [Related]  

  • 51. The Stop TB Partnership for Europe: aims and principles.
    O'Toole J
    Euro Surveill; 2007 Mar; 12(3):E070322.2. PubMed ID: 17439791
    [No Abstract]   [Full Text] [Related]  

  • 52. Epidemic intelligence in the European Union: strengthening the ties.
    Coulombier D
    Euro Surveill; 2008 Feb; 13(6):. PubMed ID: 18445427
    [No Abstract]   [Full Text] [Related]  

  • 53. European regions come of age.
    Brugmans H
    Health Policy; 1993 Oct; 25(3):187-97. PubMed ID: 10171725
    [No Abstract]   [Full Text] [Related]  

  • 54. Building international collaborative capacity: contributions of community psychologists to a European network.
    García-Ramírez M; Paloma V; Suarez-Balcazar Y; Balcazar F
    Am J Community Psychol; 2009 Sep; 44(1-2):116-22. PubMed ID: 19533330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Piloting international production of rapid relative effectiveness assessments of pharmaceuticals.
    Kleijnen S; Pasternack I; Rannanheimo P; Vuola JM; Van de Casteele M; Bucsics A; Pulis IZ; Di Bidino R; Sacchini D; Montilla S; Abrishami P; Sammut SM; Muscolo LA; Happonen P; Goettsch WG
    Int J Technol Assess Health Care; 2014 Nov; 30(5):521-9. PubMed ID: 25747562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health technology assessment for medical devices in Europe. What must be considered.
    Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
    Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interests in health care technology assessment (HCTA) and HCTA training needs in eight European countries: COMETT-ASSESS.
    Szczepura A; Kankaanpää J
    Soc Sci Med; 1994 Jun; 38(12):1679-88. PubMed ID: 8047927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Collaborative models for the joint production of core health technology assessments: negative and positive aspects for the joint work of different European agencies.
    Lo Scalzo A; Vicari N; Corio M; Perrini MR; Jefferson T; Gillespie F; Cerbo M
    Int J Technol Assess Health Care; 2014 Nov; 30(5):536-43. PubMed ID: 25747564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Europe we want-a Transatlantic Health and Wellbeing Partnership?
    Dyakova M; Weiss M; Middleton J; Bellis MA
    Eur J Public Health; 2015 Aug; 25(4):553-4. PubMed ID: 26207025
    [No Abstract]   [Full Text] [Related]  

  • 60. THE ADDED VALUE OF INTEGRATE-HTA GUIDANCE IN THE WORK PROCESSES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES.
    van der Wilt GJ; Kievit W; Oortwijn W
    Int J Technol Assess Health Care; 2017 Jan; 33(5):597-598. PubMed ID: 29113611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.